<DOC>
	<DOC>NCT00849043</DOC>
	<brief_summary>The purpose of this study is to evaluate the long-term durability of the treatment and safety of the Provent device for those individuals who were enrolled in the C009 study, were diagnosed with obstructive sleep apnea-hypopnea (OSAH), and were actively using the Provent device.</brief_summary>
	<brief_title>Extension Study of Original Protocol AERO C009 for Obstructive Sleep Apnea-hypopnea</brief_title>
	<detailed_description />
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea, Obstructive</mesh_term>
	<criteria>1. Based upon scoring at the study site, the 3month 'device on' PSG has a 50% reduction in AHI compared to the 1week 'device off' PSG AHI OR the 3month 'device on' PSG AHI &lt;10 2. Used the Provent device at least 4 hours for at least 5/7 nights per week on average during months 1 and 2 of the three month C009 study 3. The study physician and investigator believe that continued Provent use does not represent a significant safety risk for the patient 4. Patient understands and is willing and able to comply with study requirements 1. The patient must continue to not meet all of the exclusion criteria of protocol C009</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>obstructive sleep apnea hypopnea</keyword>
	<keyword>OSA</keyword>
	<keyword>OSAH</keyword>
</DOC>